<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph id="IAS41_B49" base="SL33551"><paranum>B49</paranum><prolog><data name="standard_number" value="IASÂ 41"/><data name="paranum" value="B49"/></prolog><body><p id="IAS41_P0836">Some argue that contract prices should be used in measuring the related biological assets when an entity expects to settle the contract by delivery and believe this would result in the most relevant carrying amount for the biological asset. Others argue that contract prices are not necessarily relevant in measuring the biological assets at fair value since fair value reflects the current market in which a willing buyer and seller would enter into a transaction.<xref keyref="footnotes/IAS41_FN0022" type="fn"/></p></body></paragraph>